世界のインフルエンザ治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Influenza Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4367 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、インフルエンザ治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ワクチン、医薬品）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・インフルエンザ治療薬の市場動向 ・企業の競争状況、市場シェア ・インフルエンザ治療薬の種類別市場規模と予測2016-2027（ワクチン、医薬品） ・インフルエンザ治療薬の用途別市場規模と予測2016-2027（病院、クリニック、その他） ・インフルエンザ治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・インフルエンザ治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・インフルエンザ治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・インフルエンザ治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・インフルエンザ治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott Laboratories、Astrazeneca PLC、Biocryst Pharmaceuticals, Inc.、Chiron Corporation、CSL Limited、Daiichi Sankyo Co., Ltd.、Glaxosmithkline PLC、Mitsubishi Tanabe Pharma Corporation、Nanotherapeutics Inc.、Protein Sciences Corporation、Roche Holding AG、Sanofi SA、Shionogi & Co., Ltd.、Sinovac Biotech Ltd.） ・結論

Influenza, commonly known as the flu, is an infectious disease caused by an influenza virus.

Market Analysis and Insights: Global Influenza Therapeutics Market
The global Influenza Therapeutics market size is projected to reach US$ 9521.1 million by 2027, from US$ 6644.2 million in 2020, at a CAGR of 4.8% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Influenza Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Influenza Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Influenza Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Influenza Therapeutics market.

Global Influenza Therapeutics Scope and Market Size
Influenza Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Influenza Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Vaccines
Drugs

Segment by Application
Hospitals
Clinic
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott Laboratories
Astrazeneca PLC
Biocryst Pharmaceuticals, Inc.
Chiron Corporation
CSL Limited
Daiichi Sankyo Co., Ltd.
Glaxosmithkline PLC
Mitsubishi Tanabe Pharma Corporation
Nanotherapeutics Inc.
Protein Sciences Corporation
Roche Holding AG
Sanofi SA
Shionogi & Co., Ltd.
Sinovac Biotech Ltd.

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Influenza Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Vaccines
1.2.3 Drugs
1.3 Market by Application
1.3.1 Global Influenza Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Influenza Therapeutics Market Perspective (2016-2027)
2.2 Influenza Therapeutics Growth Trends by Regions
2.2.1 Influenza Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Influenza Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Influenza Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Influenza Therapeutics Industry Dynamic
2.3.1 Influenza Therapeutics Market Trends
2.3.2 Influenza Therapeutics Market Drivers
2.3.3 Influenza Therapeutics Market Challenges
2.3.4 Influenza Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Influenza Therapeutics Players by Revenue
3.1.1 Global Top Influenza Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Influenza Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Influenza Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Influenza Therapeutics Revenue
3.4 Global Influenza Therapeutics Market Concentration Ratio
3.4.1 Global Influenza Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Influenza Therapeutics Revenue in 2020
3.5 Influenza Therapeutics Key Players Head office and Area Served
3.6 Key Players Influenza Therapeutics Product Solution and Service
3.7 Date of Enter into Influenza Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Influenza Therapeutics Breakdown Data by Type
4.1 Global Influenza Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Influenza Therapeutics Forecasted Market Size by Type (2022-2027)

5 Influenza Therapeutics Breakdown Data by Application
5.1 Global Influenza Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Influenza Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Influenza Therapeutics Market Size (2016-2027)
6.2 North America Influenza Therapeutics Market Size by Type
6.2.1 North America Influenza Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Influenza Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Influenza Therapeutics Market Size by Type (2016-2027)
6.3 North America Influenza Therapeutics Market Size by Application
6.3.1 North America Influenza Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Influenza Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Influenza Therapeutics Market Size by Application (2016-2027)
6.4 North America Influenza Therapeutics Market Size by Country
6.4.1 North America Influenza Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Influenza Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Influenza Therapeutics Market Size (2016-2027)
7.2 Europe Influenza Therapeutics Market Size by Type
7.2.1 Europe Influenza Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Influenza Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Influenza Therapeutics Market Size by Type (2016-2027)
7.3 Europe Influenza Therapeutics Market Size by Application
7.3.1 Europe Influenza Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Influenza Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Influenza Therapeutics Market Size by Application (2016-2027)
7.4 Europe Influenza Therapeutics Market Size by Country
7.4.1 Europe Influenza Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Influenza Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Influenza Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Influenza Therapeutics Market Size by Type
8.2.1 Asia-Pacific Influenza Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Influenza Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Influenza Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Influenza Therapeutics Market Size by Application
8.3.1 Asia-Pacific Influenza Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Influenza Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Influenza Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Influenza Therapeutics Market Size by Region
8.4.1 Asia-Pacific Influenza Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Influenza Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Influenza Therapeutics Market Size (2016-2027)
9.2 Latin America Influenza Therapeutics Market Size by Type
9.2.1 Latin America Influenza Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Influenza Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Influenza Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Influenza Therapeutics Market Size by Application
9.3.1 Latin America Influenza Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Influenza Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Influenza Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Influenza Therapeutics Market Size by Country
9.4.1 Latin America Influenza Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Influenza Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Influenza Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Influenza Therapeutics Market Size by Type
10.2.1 Middle East & Africa Influenza Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Influenza Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Influenza Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Influenza Therapeutics Market Size by Application
10.3.1 Middle East & Africa Influenza Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Influenza Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Influenza Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Influenza Therapeutics Market Size by Country
10.4.1 Middle East & Africa Influenza Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Influenza Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Influenza Therapeutics Introduction
11.1.4 Abbott Laboratories Revenue in Influenza Therapeutics Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 Astrazeneca PLC
11.2.1 Astrazeneca PLC Company Details
11.2.2 Astrazeneca PLC Business Overview
11.2.3 Astrazeneca PLC Influenza Therapeutics Introduction
11.2.4 Astrazeneca PLC Revenue in Influenza Therapeutics Business (2016-2021)
11.2.5 Astrazeneca PLC Recent Development
11.3 Biocryst Pharmaceuticals, Inc.
11.3.1 Biocryst Pharmaceuticals, Inc. Company Details
11.3.2 Biocryst Pharmaceuticals, Inc. Business Overview
11.3.3 Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Introduction
11.3.4 Biocryst Pharmaceuticals, Inc. Revenue in Influenza Therapeutics Business (2016-2021)
11.3.5 Biocryst Pharmaceuticals, Inc. Recent Development
11.4 Chiron Corporation
11.4.1 Chiron Corporation Company Details
11.4.2 Chiron Corporation Business Overview
11.4.3 Chiron Corporation Influenza Therapeutics Introduction
11.4.4 Chiron Corporation Revenue in Influenza Therapeutics Business (2016-2021)
11.4.5 Chiron Corporation Recent Development
11.5 CSL Limited
11.5.1 CSL Limited Company Details
11.5.2 CSL Limited Business Overview
11.5.3 CSL Limited Influenza Therapeutics Introduction
11.5.4 CSL Limited Revenue in Influenza Therapeutics Business (2016-2021)
11.5.5 CSL Limited Recent Development
11.6 Daiichi Sankyo Co., Ltd.
11.6.1 Daiichi Sankyo Co., Ltd. Company Details
11.6.2 Daiichi Sankyo Co., Ltd. Business Overview
11.6.3 Daiichi Sankyo Co., Ltd. Influenza Therapeutics Introduction
11.6.4 Daiichi Sankyo Co., Ltd. Revenue in Influenza Therapeutics Business (2016-2021)
11.6.5 Daiichi Sankyo Co., Ltd. Recent Development
11.7 Glaxosmithkline PLC
11.7.1 Glaxosmithkline PLC Company Details
11.7.2 Glaxosmithkline PLC Business Overview
11.7.3 Glaxosmithkline PLC Influenza Therapeutics Introduction
11.7.4 Glaxosmithkline PLC Revenue in Influenza Therapeutics Business (2016-2021)
11.7.5 Glaxosmithkline PLC Recent Development
11.8 Mitsubishi Tanabe Pharma Corporation
11.8.1 Mitsubishi Tanabe Pharma Corporation Company Details
11.8.2 Mitsubishi Tanabe Pharma Corporation Business Overview
11.8.3 Mitsubishi Tanabe Pharma Corporation Influenza Therapeutics Introduction
11.8.4 Mitsubishi Tanabe Pharma Corporation Revenue in Influenza Therapeutics Business (2016-2021)
11.8.5 Mitsubishi Tanabe Pharma Corporation Recent Development
11.9 Nanotherapeutics Inc.
11.9.1 Nanotherapeutics Inc. Company Details
11.9.2 Nanotherapeutics Inc. Business Overview
11.9.3 Nanotherapeutics Inc. Influenza Therapeutics Introduction
11.9.4 Nanotherapeutics Inc. Revenue in Influenza Therapeutics Business (2016-2021)
11.9.5 Nanotherapeutics Inc. Recent Development
11.10 Protein Sciences Corporation
11.10.1 Protein Sciences Corporation Company Details
11.10.2 Protein Sciences Corporation Business Overview
11.10.3 Protein Sciences Corporation Influenza Therapeutics Introduction
11.10.4 Protein Sciences Corporation Revenue in Influenza Therapeutics Business (2016-2021)
11.10.5 Protein Sciences Corporation Recent Development
11.11 Roche Holding AG
11.11.1 Roche Holding AG Company Details
11.11.2 Roche Holding AG Business Overview
11.11.3 Roche Holding AG Influenza Therapeutics Introduction
11.11.4 Roche Holding AG Revenue in Influenza Therapeutics Business (2016-2021)
11.11.5 Roche Holding AG Recent Development
11.12 Sanofi SA
11.12.1 Sanofi SA Company Details
11.12.2 Sanofi SA Business Overview
11.12.3 Sanofi SA Influenza Therapeutics Introduction
11.12.4 Sanofi SA Revenue in Influenza Therapeutics Business (2016-2021)
11.12.5 Sanofi SA Recent Development
11.13 Shionogi & Co., Ltd.
11.13.1 Shionogi & Co., Ltd. Company Details
11.13.2 Shionogi & Co., Ltd. Business Overview
11.13.3 Shionogi & Co., Ltd. Influenza Therapeutics Introduction
11.13.4 Shionogi & Co., Ltd. Revenue in Influenza Therapeutics Business (2016-2021)
11.13.5 Shionogi & Co., Ltd. Recent Development
11.14 Sinovac Biotech Ltd.
11.14.1 Sinovac Biotech Ltd. Company Details
11.14.2 Sinovac Biotech Ltd. Business Overview
11.14.3 Sinovac Biotech Ltd. Influenza Therapeutics Introduction
11.14.4 Sinovac Biotech Ltd. Revenue in Influenza Therapeutics Business (2016-2021)
11.14.5 Sinovac Biotech Ltd. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Influenza Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Vaccines
Table 3. Key Players of Drugs
Table 4. Global Influenza Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Influenza Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Influenza Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Influenza Therapeutics Market Share by Regions (2016-2021)
Table 8. Global Influenza Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Influenza Therapeutics Market Share by Regions (2022-2027)
Table 10. Influenza Therapeutics Market Trends
Table 11. Influenza Therapeutics Market Drivers
Table 12. Influenza Therapeutics Market Challenges
Table 13. Influenza Therapeutics Market Restraints
Table 14. Global Influenza Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Influenza Therapeutics Market Share by Players (2016-2021)
Table 16. Global Top Influenza Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Therapeutics as of 2020)
Table 17. Ranking of Global Top Influenza Therapeutics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Influenza Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Influenza Therapeutics Product Solution and Service
Table 21. Date of Enter into Influenza Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Influenza Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Influenza Therapeutics Revenue Market Share by Type (2016-2021)
Table 25. Global Influenza Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Influenza Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Influenza Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Influenza Therapeutics Revenue Market Share by Application (2016-2021)
Table 29. Global Influenza Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Influenza Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Influenza Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Influenza Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Influenza Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Influenza Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Influenza Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Influenza Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Influenza Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Influenza Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Influenza Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Influenza Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Influenza Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Influenza Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Influenza Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Influenza Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Influenza Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Influenza Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Influenza Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Influenza Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Influenza Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Influenza Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Influenza Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Influenza Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Influenza Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Influenza Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Influenza Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Influenza Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Influenza Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Influenza Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Influenza Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Influenza Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 61. Abbott Laboratories Company Details
Table 62. Abbott Laboratories Business Overview
Table 63. Abbott Laboratories Influenza Therapeutics Product
Table 64. Abbott Laboratories Revenue in Influenza Therapeutics Business (2016-2021) & (US$ Million)
Table 65. Abbott Laboratories Recent Development
Table 66. Astrazeneca PLC Company Details
Table 67. Astrazeneca PLC Business Overview
Table 68. Astrazeneca PLC Influenza Therapeutics Product
Table 69. Astrazeneca PLC Revenue in Influenza Therapeutics Business (2016-2021) & (US$ Million)
Table 70. Astrazeneca PLC Recent Development
Table 71. Biocryst Pharmaceuticals, Inc. Company Details
Table 72. Biocryst Pharmaceuticals, Inc. Business Overview
Table 73. Biocryst Pharmaceuticals, Inc. Influenza Therapeutics Product
Table 74. Biocryst Pharmaceuticals, Inc. Revenue in Influenza Therapeutics Business (2016-2021) & (US$ Million)
Table 75. Biocryst Pharmaceuticals, Inc. Recent Development
Table 76. Chiron Corporation Company Details
Table 77. Chiron Corporation Business Overview
Table 78. Chiron Corporation Influenza Therapeutics Product
Table 79. Chiron Corporation Revenue in Influenza Therapeutics Business (2016-2021) & (US$ Million)
Table 80. Chiron Corporation Recent Development
Table 81. CSL Limited Company Details
Table 82. CSL Limited Business Overview
Table 83. CSL Limited Influenza Therapeutics Product
Table 84. CSL Limited Revenue in Influenza Therapeutics Business (2016-2021) & (US$ Million)
Table 85. CSL Limited Recent Development
Table 86. Daiichi Sankyo Co., Ltd. Company Details
Table 87. Daiichi Sankyo Co., Ltd. Business Overview
Table 88. Daiichi Sankyo Co., Ltd. Influenza Therapeutics Product
Table 89. Daiichi Sankyo Co., Ltd. Revenue in Influenza Therapeutics Business (2016-2021) & (US$ Million)
Table 90. Daiichi Sankyo Co., Ltd. Recent Development
Table 91. Glaxosmithkline PLC Company Details
Table 92. Glaxosmithkline PLC Business Overview
Table 93. Glaxosmithkline PLC Influenza Therapeutics Product
Table 94. Glaxosmithkline PLC Revenue in Influenza Therapeutics Business (2016-2021) & (US$ Million)
Table 95. Glaxosmithkline PLC Recent Development
Table 96. Mitsubishi Tanabe Pharma Corporation Company Details
Table 97. Mitsubishi Tanabe Pharma Corporation Business Overview
Table 98. Mitsubishi Tanabe Pharma Corporation Revenue in Influenza Therapeutics Business (2016-2021) & (US$ Million)
Table 99. Mitsubishi Tanabe Pharma Corporation Recent Development
Table 100. Nanotherapeutics Inc. Company Details
Table 101. Nanotherapeutics Inc. Business Overview
Table 102. Nanotherapeutics Inc. Influenza Therapeutics Product
Table 103. Nanotherapeutics Inc. Revenue in Influenza Therapeutics Business (2016-2021) & (US$ Million)
Table 104. Nanotherapeutics Inc. Recent Development
Table 105. Protein Sciences Corporation Company Details
Table 106. Protein Sciences Corporation Business Overview
Table 107. Protein Sciences Corporation Influenza Therapeutics Product
Table 108. Protein Sciences Corporation Revenue in Influenza Therapeutics Business (2016-2021) & (US$ Million)
Table 109. Protein Sciences Corporation Recent Development
Table 110. Roche Holding AG Company Details
Table 111. Roche Holding AG Business Overview
Table 112. Roche Holding AG Influenza Therapeutics Product
Table 113. Roche Holding AG Revenue in Influenza Therapeutics Business (2016-2021) & (US$ Million)
Table 114. Roche Holding AG Recent Development
Table 115. Sanofi SA Company Details
Table 116. Sanofi SA Business Overview
Table 117. Sanofi SA Influenza Therapeutics Product
Table 118. Sanofi SA Revenue in Influenza Therapeutics Business (2016-2021) & (US$ Million)
Table 119. Sanofi SA Recent Development
Table 120. Shionogi & Co., Ltd. Company Details
Table 121. Shionogi & Co., Ltd. Business Overview
Table 122. Shionogi & Co., Ltd. Influenza Therapeutics Product
Table 123. Shionogi & Co., Ltd. Revenue in Influenza Therapeutics Business (2016-2021) & (US$ Million)
Table 124. Shionogi & Co., Ltd. Recent Development
Table 125. Sinovac Biotech Ltd. Company Details
Table 126. Sinovac Biotech Ltd. Business Overview
Table 127. Sinovac Biotech Ltd. Influenza Therapeutics Product
Table 128. Sinovac Biotech Ltd. Revenue in Influenza Therapeutics Business (2016-2021) & (US$ Million)
Table 129. Sinovac Biotech Ltd. Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Influenza Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Vaccines Features
Figure 3. Drugs Features
Figure 4. Global Influenza Therapeutics Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Clinic Case Studies
Figure 7. Others Case Studies
Figure 8. Influenza Therapeutics Report Years Considered
Figure 9. Global Influenza Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Influenza Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Influenza Therapeutics Market Share by Regions: 2020 VS 2027
Figure 12. Global Influenza Therapeutics Market Share by Regions (2022-2027)
Figure 13. Global Influenza Therapeutics Market Share by Players in 2020
Figure 14. Global Top Influenza Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Therapeutics as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Influenza Therapeutics Revenue in 2020
Figure 16. Global Influenza Therapeutics Revenue Market Share by Type (2016-2021)
Figure 17. Global Influenza Therapeutics Revenue Market Share by Type (2022-2027)
Figure 18. North America Influenza Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Influenza Therapeutics Market Share by Type (2016-2027)
Figure 20. North America Influenza Therapeutics Market Share by Application (2016-2027)
Figure 21. North America Influenza Therapeutics Market Share by Country (2016-2027)
Figure 22. United States Influenza Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Influenza Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Influenza Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Influenza Therapeutics Market Share by Type (2016-2027)
Figure 26. Europe Influenza Therapeutics Market Share by Application (2016-2027)
Figure 27. Europe Influenza Therapeutics Market Share by Country (2016-2027)
Figure 28. Germany Influenza Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Influenza Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Influenza Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Influenza Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Influenza Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Influenza Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Influenza Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Influenza Therapeutics Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Influenza Therapeutics Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Influenza Therapeutics Market Share by Region (2016-2027)
Figure 38. China Influenza Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Influenza Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Influenza Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Influenza Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Influenza Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Influenza Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Influenza Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Influenza Therapeutics Market Share by Type (2016-2027)
Figure 46. Latin America Influenza Therapeutics Market Share by Application (2016-2027)
Figure 47. Latin America Influenza Therapeutics Market Share by Country (2016-2027)
Figure 48. Mexico Influenza Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Influenza Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Influenza Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Influenza Therapeutics Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Influenza Therapeutics Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Influenza Therapeutics Market Share by Country (2016-2027)
Figure 54. Turkey Influenza Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Influenza Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Influenza Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Abbott Laboratories Revenue Growth Rate in Influenza Therapeutics Business (2016-2021)
Figure 58. Astrazeneca PLC Revenue Growth Rate in Influenza Therapeutics Business (2016-2021)
Figure 59. Biocryst Pharmaceuticals, Inc. Revenue Growth Rate in Influenza Therapeutics Business (2016-2021)
Figure 60. Chiron Corporation Revenue Growth Rate in Influenza Therapeutics Business (2016-2021)
Figure 61. CSL Limited Revenue Growth Rate in Influenza Therapeutics Business (2016-2021)
Figure 62. Daiichi Sankyo Co., Ltd. Revenue Growth Rate in Influenza Therapeutics Business (2016-2021)
Figure 63. Glaxosmithkline PLC Revenue Growth Rate in Influenza Therapeutics Business (2016-2021)
Figure 64. Mitsubishi Tanabe Pharma Corporation Revenue Growth Rate in Influenza Therapeutics Business (2016-2021)
Figure 65. Nanotherapeutics Inc. Revenue Growth Rate in Influenza Therapeutics Business (2016-2021)
Figure 66. Protein Sciences Corporation Revenue Growth Rate in Influenza Therapeutics Business (2016-2021)
Figure 67. Roche Holding AG Revenue Growth Rate in Influenza Therapeutics Business (2016-2021)
Figure 68. Sanofi SA Revenue Growth Rate in Influenza Therapeutics Business (2016-2021)
Figure 69. Shionogi & Co., Ltd. Revenue Growth Rate in Influenza Therapeutics Business (2016-2021)
Figure 70. Sinovac Biotech Ltd. Revenue Growth Rate in Influenza Therapeutics Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

---